07 Nov Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes
Posted at 00:00h
in
Authored by: Falzon D, Gandhi N, Migliori GB, Sotgiu G, Cox HS, Holtz TH, Hollm-Delgado MG, Keshavjee S, DeRiemer K, Centis R, D’Ambrosio L, Lange CG, Bauer M, Menzies D, Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB.
In: Eur Respir J., 2013, 156-68
http://www.ncbi.nlm.nih.gov/pubmed/23100499